DR info

Clinical trials : 8 / Drugs : 7 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathway : 1

Mixed connective tissue disease and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
52	Mixed connective tissue disease
36	Epidermolysis bullosa
13	Multiple sclerosis/Neuromyelitis optica
6	Parkinson disease
63	Idiopathic thrombocytopenic purpura
94	Primary sclerosing cholangitis
17	Multiple system atrophy
19	Lysosomal storage disease
35	Pemphigus
46	Malignant rheumatoid arthritis
49	Systemic lupus erythematosus
51	Scleroderma
60	Aplastic anemia
61	Autoimmune hemolytic anemia
65	Primary immunodeficiency
66	IgA nephropathy
84	Sarcoidosis
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
96	Crohn disease
127	Frontotemporal lobar degeneration
222	Primary nephrotic syndrome
256	Muscle glycogenosis
283	Acquired pure red cell aplasia
285	Fanconi anemia
331	Idiopathic multicentric castleman disease
53	Sjogren syndrome
271	Ankylosing spondylitis
162	Pemphigoid
93	Primary biliary cholangitis
50	Dermatomyositis
56	Behcet disease
97	Ulcerative colitis
300	IgG4-related disease
296	Biliary atresia
41	Giant cell arteritis
42	Polyarteritis nodosa
43	Microscopic polyangiitis
45	Eosinophilic granulomatosis with Polyangiitis
55	Relapsing polychondritis
284	Diamond-Blackfan anemia
11	Myasthenia gravis
44	Wegener granulomatosis
288	Autoimmune acquired coagulation factor deficiency
274	Osteogenesis Imperfecta
14	Chronic inflammatory demyelinating polyneuropathy
83	Addison disease
64	Thrombotic thrombocytopenic purpura
229	Autoimmune pulmonary alveolar proteinosis